LobbyingBrightspring Health Services lobbying by quarter
Brightspring Health Services BTSG's latest lobbying report covers Q2 2026, at $110K. The four quarters Q3 2025–Q2 2026 total $1.2M. Its first report covers Q2 2025; the issues it reports most are Medicare/Medicaid and Pharmacy.
- Latest quarter
- $110K
- Q2 2026 · 2 reports
- Last 12 months
- $1.2M
- Last 4 quarters
- vs last quarter
- −66.7%
- Q2 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $270K | 3 |
| Q3 2025 | $360K | 3 |
| Q4 2025 | $360K | 3 |
| Q1 2026 | $330K | 3 |
| Q2 2026 | $110K | 2 |
Policy issues the reports name
- Medicare and Medicaid12 reports
- Pharmacy12 reports
- Health issues10 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES14 reports
- SENATE14 reports
- Health & Human Services, Dept of (HHS)5 reports
- Centers For Medicare and Medicaid Services (CMS)4 reports
- White House Office4 reports
- Executive Office of the President (EOP)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseBrightspring Health Services | $920K | 4 quarters |
| Federal Health Policy Strategies | $370K | 5 quarters |
| Akin Gump Strauss Hauer & Feld | $140K | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Federal Health Policy Strategies | $80K |
| 07/20for Q2 | Akin Gump Strauss Hauer & Feld | $30K |
| 04/20for Q1 | Akin Gump Strauss Hauer & Feld | $30K |
| 04/20for Q1 | Federal Health Policy Strategies | $80K |
| 04/17for Q1 | In-house | $220K |
| 04/17for Q1 | In-house | $220K |
| 03/13for Q4 2025 | In-house | $250K |
| 03/13for Q3 2025 | In-house | $250K |
| 03/13for Q2 2025 | In-house | $200K |
| 01/20for Q4 2025 | In-house | $40K |
| 01/20for Q4 2025 | Akin Gump Strauss Hauer & Feld | $30K |
| 01/20for Q4 2025 | Federal Health Policy Strategies | $80K |
| 25/10/20for Q3 2025 | Akin Gump Strauss Hauer & Feld | $30K |
| 25/10/20for Q3 2025 | Federal Health Policy Strategies | $80K |
| 25/10/17for Q3 2025 | In-house | $20K |
| 25/07/28for Q2 2025 | In-house | $10K |
| 25/07/21for Q2 2025 | Akin Gump Strauss Hauer & Feld | $20K |
| 25/07/21for Q2 2025 | Federal Health Policy Strategies | $50K |
| 25/07/08for Q2 2025 | Federal Health Policy Strategies | Under $5,000 |
| 25/06/17for Q2 2025 | In-house | Under $5,000 |